108 related articles for article (PubMed ID: 17449174)
1. Origin and prognostic value of circulating KRAS mutations in lung cancer patients.
Gautschi O; Huegli B; Ziegler A; Gugger M; Heighway J; Ratschiller D; Mack PC; Gumerlock PH; Kung HJ; Stahel RA; Gandara DR; Betticher DC
Cancer Lett; 2007 Sep; 254(2):265-73. PubMed ID: 17449174
[TBL] [Abstract][Full Text] [Related]
2. The relationship between KRAS gene mutations and HLA class I antigen downregulation in the metastasis of non-small cell lung cancer.
He XP; Song FJ; Liu XY; Wang Z; Li XX; Liu FY; Chen G; Jiang WP
J Int Med Res; 2013 Oct; 41(5):1473-83. PubMed ID: 23975858
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor DNA outperforms circulating tumor cells for KRAS mutation detection in thoracic malignancies.
Freidin MB; Freydina DV; Leung M; Montero Fernandez A; Nicholson AG; Lim E
Clin Chem; 2015 Oct; 61(10):1299-304. PubMed ID: 26272233
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing peripheral lung cancer: the additional value of the Ras-association domain family 1A gene methylation and Kirsten rat sarcoma 2 viral oncogene homolog mutation analyses in washings in nondiagnostic bronchoscopy.
van der Drift MA; Prinsen CFM; Knuiman GJ; Janssen JP; Dekhuijzen PNR; Thunnissen FBJM
Chest; 2012 Jan; 141(1):169-175. PubMed ID: 21700687
[TBL] [Abstract][Full Text] [Related]
5. No duplicate KRAS mutation is identified on the same allele in gastric or colorectal cancer cells with multiple KRAS mutations.
Kimura K; Nagasaka T; Hoshizima N; Sasamoto H; Notohara K; Takeda M; Kominami K; Iishii T; Tanaka N; Matsubara N
J Int Med Res; 2007; 35(4):450-7. PubMed ID: 17697521
[TBL] [Abstract][Full Text] [Related]
6. Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler.
Sasaki H; Okuda K; Kawano O; Endo K; Yukiue H; Yokoyama T; Yano M; Fujii Y
Oncol Rep; 2007 Sep; 18(3):623-8. PubMed ID: 17671710
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis.
Meng D; Yuan M; Li X; Chen L; Yang J; Zhao X; Ma W; Xin J
Lung Cancer; 2013 Jul; 81(1):1-10. PubMed ID: 23608713
[TBL] [Abstract][Full Text] [Related]
8. Analysis of circulating tumor DNA to confirm somatic KRAS mutations.
Holdhoff M; Schmidt K; Donehower R; Diaz LA
J Natl Cancer Inst; 2009 Sep; 101(18):1284-5. PubMed ID: 19641175
[No Abstract] [Full Text] [Related]
9. Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.
Dobrzycka B; Terlikowski SJ; Mazurek A; Kowalczuk O; Niklińska W; Chyczewski L; Kulikowski M
Folia Histochem Cytobiol; 2009; 47(1):65-8. PubMed ID: 19419940
[TBL] [Abstract][Full Text] [Related]
10. [Detection of KRAS mutations in tumor cells using biochips].
Emel'ianova MA; Amosenko FA; Chudinov AV; Surzhikov SA; Kazubskaia TP; Liubchenko LN; Nasedkina TV
Mol Biol (Mosk); 2011; 45(5):863-70. PubMed ID: 22393783
[TBL] [Abstract][Full Text] [Related]
11. Co-amplification at lower denaturation-temperature PCR combined with unlabled-probe high-resolution melting to detect KRAS codon 12 and 13 mutations in plasma-circulating DNA of pancreatic adenocarcinoma cases.
Wu J; Zhou Y; Zhang CY; Song BB; Wang BL; Pan BS; Lou WH; Guo W
Asian Pac J Cancer Prev; 2014; 15(24):10647-52. PubMed ID: 25605154
[TBL] [Abstract][Full Text] [Related]
12. Detection of low-abundance KRAS mutations in colorectal cancer using microfluidic capillary electrophoresis-based restriction fragment length polymorphism method with optimized assay conditions.
Zhang H; Song J; Ren H; Xu Z; Wang X; Shan L; Fang J
PLoS One; 2013; 8(1):e54510. PubMed ID: 23355875
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the KRAS gene in ovarian tumors.
Dobrzycka B; Terlikowski SJ; Kowalczuk O; Niklińska W; Chyczewski L; Kulikowski M
Folia Histochem Cytobiol; 2009; 47(2):221-4. PubMed ID: 19995707
[TBL] [Abstract][Full Text] [Related]
14. Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass.
Maluf-Filho F; Kumar A; Gerhardt R; Kubrusly M; Sakai P; Hondo F; Matuguma SE; Artifon E; Monteiro da Cunha JE; César Machado MC; Ishioka S; Forero E
J Clin Gastroenterol; 2007; 41(10):906-10. PubMed ID: 18090159
[TBL] [Abstract][Full Text] [Related]
15. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.
Lecomte T; Berger A; Zinzindohoué F; Micard S; Landi B; Blons H; Beaune P; Cugnenc PH; Laurent-Puig P
Int J Cancer; 2002 Aug; 100(5):542-8. PubMed ID: 12124803
[TBL] [Abstract][Full Text] [Related]
16. Lack of KRAS gene mutations in chronic myeloid leukemia in Iran.
Kooshyar MM; Ayatollahi H; Keramati MR; Sadeghian MH; Miri M; Sheikhi M
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6653-6. PubMed ID: 24377583
[TBL] [Abstract][Full Text] [Related]
17. K-ras mutations in circulating DNA from pancreatic and lung cancers: bridging methodology for a common validation of the molecular diagnosis value.
Magistrelli P; Neri M; Granone P; Cesario A; Paleari L; Russo P
Pancreas; 2008 Jul; 37(1):101-2. PubMed ID: 18580451
[No Abstract] [Full Text] [Related]
18. Interlaboratory comparison of K-ras testing by real-time PCR and RFLP in colorectal cancer samples.
Lanthaler AJ; Spizzo G; Mitterer M; Mian C; Mazzoleni G
Diagn Mol Pathol; 2011 Jun; 20(2):90-3. PubMed ID: 21532493
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of specific KRAS mutations in lung adenocarcinomas.
Siegfried JM; Gillespie AT; Mera R; Casey TJ; Keohavong P; Testa JR; Hunt JD
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):841-7. PubMed ID: 9332768
[TBL] [Abstract][Full Text] [Related]
20. Optimization of circulating cell-free DNA recovery for KRAS mutation and HPV detection in plasma.
Mazurek AM; Fiszer-Kierzkowska A; Rutkowski T; Składowski K; Pierzyna M; Scieglińska D; Woźniak G; Głowacki G; Kawczyński R; Małusecka E
Cancer Biomark; 2013; 13(5):385-94. PubMed ID: 24440979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
